Overview of bladder cancer trials in the Radiation Therapy Oncology Group
Author:
Publisher
Wiley
Subject
Cancer Research,Oncology
Reference20 articles.
1. Organ-conserving approaches to muscle-invasive bladder cancer: future alternatives to radical cystectomy;Zietman;Ann Med.,2000
2. Treatment of invasive bladder cancer by cisplatin and irradiation in patients unsuited for surgery: a high success rate in clinical stage T2 tumors in a National Bladder Cancer Group trial;Shipley;JAMA.,1987
3. Neoadjuvant combined modality program with selective organ preservation for invasive bladder cancer: results of RTOG Phase III trial 8802;Tester;J Clin Oncol.,1996
4. A Phase III trial of neoadjuvant chemotherapy in patients with invasive bladder cancer treated with selective bladder preservation by combined radiation therapy and chemotherapy: initial results of RTOG 89-03;Shipley;J Clin Oncol.,1998
5. The initial results in muscle-invading bladder cancer of RTOG-95-06: Phase I/II trial of transurethral surgery plus radiation therapy with concurrent cisplatin and 5-fluorouracil followed by selective bladder preservation or cystectomy depending on the initial response;Kaufman;Oncologist.,2000
Cited by 87 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Comparing trimodal therapy with radical cystectomy in muscle-invasive bladder cancer: an updated meta-analysis;Frontiers in Surgery;2023-12-07
2. The prognostic value of urinary cytology after trimodal therapy (TMT) for muscle-invasive bladder cancer;Urologic Oncology: Seminars and Original Investigations;2022-07
3. (Nano)platforms in bladder cancer therapy: Challenges and opportunities;Bioengineering & Translational Medicine;2022-06-17
4. A phase II study of neoadjuvant chemotherapy followed by organ preservation in patients with muscle-invasive bladder cancer;Asian Journal of Urology;2021-07
5. Cdc20 induces the radioresistance of bladder cancer cells by targeting FoxO1 degradation;Cancer Letters;2021-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3